T. Rowe Price Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $267M | Sell |
5,525,745
-5,511,133
| -50% | -$266M | 0.03% | 377 |
|
2025
Q1 | $612M | Buy |
11,036,878
+193,196
| +2% | +$10.7M | 0.08% | 241 |
|
2024
Q4 | $523M | Buy |
10,843,682
+5,091,304
| +89% | +$246M | 0.06% | 259 |
|
2024
Q3 | $332M | Buy |
5,752,378
+3,890,678
| +209% | +$224M | 0.04% | 346 |
|
2024
Q2 | $90.3M | Buy |
1,861,700
+536,838
| +41% | +$26M | 0.01% | 568 |
|
2024
Q1 | $64.4M | Sell |
1,324,862
-32,835
| -2% | -$1.6M | 0.01% | 655 |
|
2023
Q4 | $67.5M | Buy |
1,357,697
+14,358
| +1% | +$714K | 0.01% | 619 |
|
2023
Q3 | $72.1M | Sell |
1,343,339
-35,589
| -3% | -$1.91M | 0.01% | 578 |
|
2023
Q2 | $74.3M | Sell |
1,378,928
-664,489
| -33% | -$35.8M | 0.01% | 591 |
|
2023
Q1 | $111M | Sell |
2,043,417
-833,389
| -29% | -$45.4M | 0.02% | 491 |
|
2022
Q4 | $139M | Sell |
2,876,806
-9,420,070
| -77% | -$456M | 0.02% | 437 |
|
2022
Q3 | $472M | Sell |
12,296,876
-4,947,478
| -29% | -$190M | 0.08% | 234 |
|
2022
Q2 | $863M | Buy |
17,244,354
+10,684,509
| +163% | +$535M | 0.11% | 199 |
|
2022
Q1 | $337M | Buy |
6,559,845
+417,741
| +7% | +$21.4M | 0.03% | 405 |
|
2021
Q4 | $308M | Buy |
6,142,104
+529,723
| +9% | +$26.5M | 0.03% | 445 |
|
2021
Q3 | $271M | Buy |
5,612,381
+1,229,367
| +28% | +$59.3M | 0.03% | 462 |
|
2021
Q2 | $231M | Sell |
4,383,014
-1,642
| -0% | -$86.5K | 0.02% | 523 |
|
2021
Q1 | $217M | Buy |
4,384,656
+1,376,204
| +46% | +$68.1M | 0.02% | 531 |
|
2020
Q4 | $146M | Buy |
3,008,452
+1,593,595
| +113% | +$77.2M | 0.02% | 606 |
|
2020
Q3 | $71M | Buy |
1,414,857
+165,341
| +13% | +$8.3M | 0.01% | 760 |
|
2020
Q2 | $63.8M | Buy |
+1,249,516
| New | +$63.8M | 0.01% | 769 |
|
2014
Q1 | – | Sell |
-5,000
| Closed | -$268K | – | 2513 |
|
2013
Q4 | $268K | Buy |
+5,000
| New | +$268K | ﹤0.01% | 2193 |
|